IN2014MN01436A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01436A IN2014MN01436A IN1436MUN2014A IN2014MN01436A IN 2014MN01436 A IN2014MN01436 A IN 2014MN01436A IN 1436MUN2014 A IN1436MUN2014 A IN 1436MUN2014A IN 2014MN01436 A IN2014MN01436 A IN 2014MN01436A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/02—Carbamic acids; Salts of carbamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161580409P | 2011-12-27 | 2011-12-27 | |
PCT/KR2012/011474 WO2013100570A1 (en) | 2011-12-27 | 2012-12-26 | Phenyl carbamate compounds for use in preventing or treating epilesy |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN01436A true IN2014MN01436A (ko) | 2015-07-03 |
Family
ID=48655156
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1432MUN2014 IN2014MN01432A (ko) | 2011-12-27 | 2014-07-15 | |
IN1436MUN2014 IN2014MN01436A (ko) | 2011-12-27 | 2014-07-15 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1432MUN2014 IN2014MN01432A (ko) | 2011-12-27 | 2014-07-15 |
Country Status (13)
Country | Link |
---|---|
US (6) | US20130184338A1 (ko) |
EP (6) | EP2797880B1 (ko) |
JP (8) | JP6089045B2 (ko) |
KR (6) | KR101795563B1 (ko) |
CN (6) | CN104136413B (ko) |
AU (2) | AU2012360362B2 (ko) |
BR (2) | BR112014015482A8 (ko) |
CA (2) | CA2859129C (ko) |
ES (3) | ES2624989T3 (ko) |
IN (2) | IN2014MN01432A (ko) |
MX (2) | MX353024B (ko) |
RU (2) | RU2632659C2 (ko) |
WO (6) | WO2013100566A1 (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
WO2013100566A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
JP6200527B2 (ja) | 2013-03-12 | 2017-09-20 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 神経保護用フェニルカルバメート化合物及びこれを含む組成物 |
JP6062077B2 (ja) * | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes} |
US9937145B2 (en) * | 2013-12-12 | 2018-04-10 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compound for use in preventing or treating epilepsy |
RU2699025C1 (ru) * | 2013-12-12 | 2019-09-03 | Био-Фарм Солутионс, Ко., Лтд. | Соединения - производные сульфамата для применения при лечении или смягчении боли |
JP6807941B2 (ja) * | 2016-02-29 | 2021-01-06 | バイオ−ファーム ソリューションズ カンパニー リミテッド | スルファメート誘導体化合物、その製造方法および用途 |
US20200237799A1 (en) | 2017-10-16 | 2020-07-30 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
KR102005019B1 (ko) | 2018-04-04 | 2019-07-31 | 한국과학기술연구원 | 뇌졸중의 예방 및 치료용 조성물 |
WO2020010035A1 (en) | 2018-07-02 | 2020-01-09 | Voyager Therapeutics, Inc. | Cannula system |
JP2021529513A (ja) | 2018-07-02 | 2021-11-04 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | 筋萎縮性側索硬化症および脊髄に関連する障害の治療 |
KR102427769B1 (ko) | 2020-08-07 | 2022-08-02 | 한국과학기술연구원 | 다발성 경화증 예방 또는 치료용 조성물 |
KR102531540B1 (ko) | 2020-09-18 | 2023-05-16 | 한국과학기술연구원 | 류마티스 관절염 예방 또는 치료용 조성물 |
KR102614653B1 (ko) | 2021-06-09 | 2023-12-20 | 한국과학기술연구원 | 신규한 헤테로사이클릴-페닐-메틸아민 유도체, 이의 제조방법 및 이의 다발성 경화증 예방, 개선, 또는 치료 용도 |
EP4382509A1 (en) | 2021-08-05 | 2024-06-12 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate crystalline form and method for preparing same |
KR102399807B1 (ko) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2884444A (en) | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
US2937119A (en) | 1959-06-11 | 1960-05-17 | Carter Prod Inc | Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates |
US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3265727A (en) | 1962-06-26 | 1966-08-09 | Armour Pharma | Phenyl alkyl-1, 2 dicarbamates |
US3313699A (en) * | 1962-06-26 | 1967-04-11 | Armour Pharma | Compositions for and method of treating the central nervous system |
US3313696A (en) | 1962-06-26 | 1967-04-11 | Armour Pharmacentical Company | Carbamate sedative compositions and method of use |
US3313700A (en) * | 1962-07-18 | 1967-04-11 | Armour Pharmacentical Company | Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor |
US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
FR5671M (ko) * | 1965-04-23 | 1968-01-02 | ||
US3600427A (en) | 1967-05-08 | 1971-08-17 | Anthony J Verbiscar | Phenyl carbamate latentiated phenethylamines |
JPS61271992A (ja) * | 1985-05-28 | 1986-12-02 | Central Glass Co Ltd | 光学活性ジオ−ルの製造方法 |
WO1994027941A1 (en) * | 1993-05-25 | 1994-12-08 | Avondale Chemical Company | Process for preparing felbamate and intermediates thereto |
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US6242468B1 (en) * | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
JP3960801B2 (ja) * | 1999-11-29 | 2007-08-15 | 三菱レイヨン株式会社 | アセタールスルホネート誘導体およびその製造方法ならびにスチレンオキサイド誘導体の製造方法 |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
JP4276838B2 (ja) | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 疼痛(pain)の治療における使用のためのカルバメート化合物 |
DE60220043T2 (de) | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen |
WO2002080902A1 (en) | 2001-04-02 | 2002-10-17 | Astrazeneca Ab | Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp |
EP1406605B1 (en) | 2001-06-25 | 2007-09-19 | SK Corporation | Carbamates of 2-heterocyclic-1,2-ethanediols |
MXPA04000554A (es) | 2001-07-16 | 2005-02-17 | Johnson & Johnson | Compuestos de carbamato para utilizarse en la prevencion o tratamiento del dolor neuropatico y el dolor asociado con la cefalea acuminada y migranosa. |
PL370977A1 (en) * | 2001-12-21 | 2005-06-13 | Ortho-Mcneil Pharmaceutical, Inc. | Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
US7385076B2 (en) | 2002-05-31 | 2008-06-10 | Sun Pharmaceutical Industries Limited | Process for the preparation of phenylcarbamates |
PT1622912E (pt) * | 2003-04-23 | 2009-08-17 | Schering Corp | Antagonistas 2-alcinil- e 2-alcenilpirazolo-[4,3-b]-1,2,4- triazolo-[1,5-c]-pirimidina do receptor a2a da adenosina |
BRPI0416268A (pt) | 2003-11-05 | 2007-12-11 | Unimed Pharmaceuticals Inc | composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla |
ES2342082T3 (es) * | 2004-04-21 | 2010-07-01 | Schering Corporation | Antagonistas de receptores a2a de adenosina de pirazolo(4,3-e)-1,2,4-triazolo(1,5-c)pirimidina. |
CA2569763C (en) * | 2004-06-08 | 2013-03-12 | Decode Chemistry, Inc. | 2,4-diaminoquinazolines for spinal muscular atrophy |
WO2006033947A2 (en) | 2004-09-16 | 2006-03-30 | Janssen Pharmaceutica, N.V. | Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy |
CN101076327A (zh) * | 2004-10-15 | 2007-11-21 | 詹森药业有限公司 | 用于治疗神经变性疾病的氨基甲酸酯化合物 |
US7442438B2 (en) | 2005-05-04 | 2008-10-28 | 3M Innovative Properties Company | Wet and dry stick adhesive, articles, and methods |
TW200800954A (en) | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
ZA200900161B (en) * | 2006-07-28 | 2010-05-26 | Eisai R&D Man Co Ltd | Prodrug of cinnamide compound |
US7737141B2 (en) * | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
WO2008045391A2 (en) * | 2006-10-06 | 2008-04-17 | Janssen Pharmaceutica Nv | Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
KR20090067210A (ko) | 2006-10-13 | 2009-06-24 | 얀센 파마슈티카 엔.브이. | 페닐알킬 카바메이트 조성물 |
AU2007319578A1 (en) | 2006-10-27 | 2008-05-22 | Janssen Pharmaceuticals, N.V. | Methods for treatment of cochlear and vestibular disorders |
AU2007313865A1 (en) | 2006-10-30 | 2008-05-08 | Janssen Pharmaceutica, N.V. | Carbamate compounds for use in treating depression |
PE20081775A1 (es) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | Compuestos macrociclicos como inhibidores del factor viia |
AU2008237019A1 (en) | 2007-04-10 | 2008-10-16 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
US20090105498A1 (en) * | 2007-10-18 | 2009-04-23 | Porstmann Frank | Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates |
JP2012500800A (ja) | 2008-08-21 | 2012-01-12 | リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ | 神経因性疼痛の治療法 |
JP2011219387A (ja) * | 2010-04-06 | 2011-11-04 | Kaneka Corp | イオン液体の製造方法 |
BR112013000050B1 (pt) * | 2010-07-02 | 2021-10-19 | Bio-Pharm Solutions Co., Ltd | Compostos de carbamato de fenila e composição farmacêutica |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
JP5838226B2 (ja) * | 2011-01-13 | 2016-01-06 | バイオ−ファーム ソリューションズ カンパニー リミテッド | フェニルカルバメート誘導体の製造方法 |
ES2543050T3 (es) * | 2011-02-28 | 2015-08-14 | Array Biopharma, Inc. | Inhibidores de serina/treonina quinasa |
WO2013100566A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
-
2012
- 2012-12-26 WO PCT/KR2012/011469 patent/WO2013100566A1/en active Application Filing
- 2012-12-26 KR KR1020147020773A patent/KR101795563B1/ko active IP Right Grant
- 2012-12-26 EP EP12862488.9A patent/EP2797880B1/en active Active
- 2012-12-26 EP EP12862332.9A patent/EP2797879B1/en active Active
- 2012-12-26 JP JP2014549992A patent/JP6089045B2/ja active Active
- 2012-12-26 AU AU2012360362A patent/AU2012360362B2/en active Active
- 2012-12-26 AU AU2012360365A patent/AU2012360365B2/en active Active
- 2012-12-26 ES ES12862488.9T patent/ES2624989T3/es active Active
- 2012-12-26 JP JP2014549991A patent/JP6155280B2/ja active Active
- 2012-12-26 CN CN201280070646.6A patent/CN104136413B/zh active Active
- 2012-12-26 EP EP12863856.6A patent/EP2797881B1/en active Active
- 2012-12-26 ES ES12863856T patent/ES2710902T3/es active Active
- 2012-12-26 JP JP2014549996A patent/JP2015504055A/ja active Pending
- 2012-12-26 BR BR112014015482A patent/BR112014015482A8/pt not_active Application Discontinuation
- 2012-12-26 ES ES12862332T patent/ES2716832T3/es active Active
- 2012-12-26 RU RU2014124028A patent/RU2632659C2/ru active
- 2012-12-26 MX MX2014008020A patent/MX353024B/es active IP Right Grant
- 2012-12-26 JP JP2014549994A patent/JP2015504054A/ja active Pending
- 2012-12-26 EP EP12862021.8A patent/EP2797878B1/en active Active
- 2012-12-26 WO PCT/KR2012/011474 patent/WO2013100570A1/en active Application Filing
- 2012-12-26 KR KR1020147017965A patent/KR101862203B1/ko active IP Right Grant
- 2012-12-26 WO PCT/KR2012/011475 patent/WO2013100571A1/en active Application Filing
- 2012-12-26 JP JP2014549993A patent/JP6298765B2/ja active Active
- 2012-12-26 WO PCT/KR2012/011470 patent/WO2013100567A1/en active Application Filing
- 2012-12-26 EP EP12861302.3A patent/EP2797876A4/en not_active Withdrawn
- 2012-12-26 RU RU2014124029A patent/RU2014124029A/ru unknown
- 2012-12-26 CN CN201280070632.4A patent/CN104169253B/zh active Active
- 2012-12-26 CA CA2859129A patent/CA2859129C/en active Active
- 2012-12-26 CN CN201280070737.XA patent/CN104870421A/zh active Pending
- 2012-12-26 WO PCT/KR2012/011472 patent/WO2013100569A1/en active Application Filing
- 2012-12-26 KR KR1020147017115A patent/KR20140113918A/ko not_active Application Discontinuation
- 2012-12-26 CN CN201280070782.5A patent/CN104136416B/zh active Active
- 2012-12-26 KR KR1020147017116A patent/KR20140113919A/ko not_active Application Discontinuation
- 2012-12-26 BR BR112014015568-2A patent/BR112014015568B1/pt active IP Right Grant
- 2012-12-26 EP EP12861408.8A patent/EP2797877A4/en not_active Withdrawn
- 2012-12-26 CN CN201280070738.4A patent/CN104136415B/zh active Active
- 2012-12-26 CA CA2858977A patent/CA2858977C/en active Active
- 2012-12-26 WO PCT/KR2012/011471 patent/WO2013100568A1/en active Application Filing
- 2012-12-26 CN CN201280070692.6A patent/CN104136414A/zh active Pending
- 2012-12-26 JP JP2014549995A patent/JP6298766B2/ja active Active
- 2012-12-26 MX MX2014008021A patent/MX338554B/es active IP Right Grant
- 2012-12-26 KR KR1020147015403A patent/KR101880584B1/ko active IP Right Grant
- 2012-12-26 KR KR1020147016928A patent/KR101795562B1/ko active IP Right Grant
- 2012-12-27 US US13/727,656 patent/US20130184338A1/en not_active Abandoned
- 2012-12-27 US US13/727,654 patent/US9624164B2/en active Active
- 2012-12-27 US US13/727,659 patent/US9029589B2/en active Active
- 2012-12-27 US US13/727,663 patent/US9162975B2/en active Active
- 2012-12-27 US US13/727,661 patent/US20130203846A1/en not_active Abandoned
- 2012-12-27 US US13/727,665 patent/US9034848B2/en active Active
-
2014
- 2014-07-15 IN IN1432MUN2014 patent/IN2014MN01432A/en unknown
- 2014-07-15 IN IN1436MUN2014 patent/IN2014MN01436A/en unknown
-
2017
- 2017-07-21 JP JP2017141920A patent/JP2017193577A/ja active Pending
-
2018
- 2018-01-10 JP JP2018001648A patent/JP2018108996A/ja active Pending